Skip to main content
. 2017 Apr 4;10:123–139. doi: 10.2147/DMSO.S130834

Figure 2.

Figure 2

Efficacy of glucose-lowering treatments in type 2 diabetes. Changes from baseline in (A) glycated hemoglobin (HbA1c), (B) fasting glucose (FG), and (C) body weight (BW) in prospective studies comparing glucagon-like peptide-1 receptor agonists (GLP-1RAs) with other oral glucose-lowering therapies and changes from baseline in (D) HbA1c, (E) FG, and (F) BW in prospective studies comparing GLP-1RAs with insulin products.

Abbreviation: DPP-4, dipeptidyl peptidase-4.